Full Test Bank - Roach’s Introductory Clinical Pharmacology, 11th Edition (Ford) – All Chapters & Topics Included (Verified A+ Study Guide)

TESTBANKVFORVROACHESVINTRODUCTORYVCLINICALV
PHARMACOLOGYV11THVEDITION


MULTIPLEVCHOICE
1. AVnursingVinstructorVisVpreparingVaVteachingVplanVforVaVgroupVofVnursingVstudents
VaboutVpharmacology.VWhenVdescribingVthisVtopic,VtheVinstructorVwouldVfocusVtheV
discussionVonVwhichVofVtheVfollowingVasVanVessentialVaspect?
A) DrugVname
B) DrugVclass
C) DrugVaction
D) DrugVsourc
eVAns:V CVFeedb
ack:
PharmacologyVisVtheVstudyVofVdrugsVandVtheirVactionVonVlivingVorganisms.VThus,V
anVessentialVaspectVofVpharmacologyVisVdrugVaction.VAnVunderstandingVofVtheVdrug
Vname,VdrugVclass,VandVdrugVsourceVisVimportant,VbutVtheVmostVcriticalVaspectVrela
tedVtoVpharmacologyVisVhowVtheVdrugVactsVinVtheVbody.


2. AVnursingVstudentVisVpreparingVtoVadministerVaVprescribedVdrugVtoVaVpatient.VTheV
studentVreviewsVinformationVaboutVtheVdrugVandVitsVactions.VWhichVofVtheVfollowin
gVwouldVbeVtheVbestVchoiceVforVobtainingVthisVinformation?VSelectVallVthatVapply.
A) NursingVinstructor
B) NurseVassignedVtoVtheVpatient
C) ClinicalVdrugVreference
D) PrescribingVhealthVcareVprovider
E) ClinicalVpharmacis
tVAns:VC,VE
Feedback:
AlthoughVtheVnursingVstudentVcanVaskVtheVnursingVinstructor,VtheVnurseVassignedVt
oVtheVpatient,VandVtheVprescribingVhealthVcareVproviderVforVinformationVaboutVtheV
drug,VtheVbestVchoicesVforVdrugVinformationVwouldVincludeVanVappropriateVdrugVre
ferenceVandVtheVclinicalVpharmacist.


3. WhenVdescribingVtheVvariousVtypesVofVmedicationsVtoVaVgroupVofVnursingVstu
dents,VaVnursingVinstructorVwouldVidentifyVwhichVofVtheVfollowingVasVaVsourc
eVforVderivingVmedications?VSelectVallVthatVapply.
A) Plants
B) SyntheticVsources
C) Mold
D) Minerals
E) AnimalsVAn
s:VA,VB,VC,VD,VE
Feedback:
MedicationsVareVderivedVfromVnaturalVsources,VforVexample,Vplants,Vmolds,Vminerals,Van
dVanimals,VasVwellVasVcreatedVsyntheticallyVinVaVlaboratory.

MedConnoisseur

,4. WhichVofVtheVfollowingVnamesVmayVbeVassignedVtoVaVdrugVduringVtheVpr
ocessVofVdevelopment?VSelectVallVthatVapply.
A) ChemicalVname
B) OfficialVname
C) PharmacologicVname
D) TradeVname
E) NonproprietaryVnam
eVAns:V A,VB,VD,VE
Feedback:
ThroughoutVtheVprocessVofVdevelopment,VdrugsVmayVhaveVseveralVnamesVassignedV
toVthemVincludingVaVchemicalVname,VaVgenericV(nonproprietary)Vname,VanVofficialV
name,VandVaVtradeVorVbrandVname.


5. AVdrugVmayVbeVclassifiedVbyVwhichVofVtheVfollowing?V SelectVallVthatVapply.
A) TheVchemicalVtypeVofVtheVdrug'sVactiveVingredient
B) TheVwayVtheVdrugVisVusedVtoVtreatVaVspecificVcondition
C) TheVgenericVnameVofVtheVdrug
D) TheVtradeVnameVofVtheVdrug
E) TheVnonproprietaryVnameVofVtheVdr
ugVAns:VA,VB
Feedback:
AVdrugVmayVbeVclassifiedVbyVtheVchemicalVtypeVofVtheVactiveVingredientVorVbyVthe
VwayVitVisVusedVtoVtreatVaVparticularVcondition.VGeneric,Vtrade,VandVnonproprietaryV
referVtoVhowVaVdrugVisVnamed.


6. AVgroupVofVnursingVstudentsVareVreviewingVinformationVaboutVtheVprocessVofVd
rugVdevelopmentVinVtheVUnitedVStates.VTheVstudentsVdemonstrateVunderstanding
VofVthisVprocessVwhenVtheyVidentifyVthatVwhichVofVtheVfollowingVcategoriesVareV
assignedVbyVtheVFoodVandVDrugVAdministrationVtoVnewlyVapprovedVdrugs?VSele
ctVallVthatVapply.
A) Metabolite
B) NoncontrolledVsubstance
C) Prescription
D) Nonprescription
E) ControlledVsubstanc
eVAns:VC,VD,VE
Feedback:
OnceVdrugsVareVapprovedVforVuse,VtheVFDAVassignsVtheVdrugVtoVoneVofVtheVfollo
wingVcategories:Vprescription,Vnonprescription,VorVcontrolledVsubstance.VMetaboliteV
refersVtoVtheVinactiveVformVofVtheVdrug.VNoncontrolledVsubstanceVisVaVtermVthatVis
VnotVused.




PageV
2

,7. WhichVofVtheVfollowingVwouldVbeVmostVimportantVforVtheVnurseVtoVdoVtoVensure
VtheVsafeVuseVofVprescriptionVdrugsVinVtheVinstitutionalVsetting?VSelectVallVthatVa
pply.
A) AdministeringVdrugs
B) MonitoringVclientsVforVdrugVeffects
C) PrescribingVdrugs
D) EvaluatingVclientsVforVtoxicVeffects
E) EducatingVclients/caregiversVaboutVdru
gsVAns:VA,VB,VD,VE
Feedback:
InVtheVinstitutionalVsetting,VtheVnurse'sVroleVtoVensureVsafeVuseVofVprescriptionVdru
gsVincludesVadministeringVdrugs,VmonitoringVdrugVeffects,VevaluatingVforVtoxicVeffe
cts,VandVeducatingVclientsVandVcaregiversVaboutVdrugs.


8. TheVnurseVisVhelpingVaVclientVreviewVaVprescriptionVfromVtheVhealthVcareVprovider
.VWhenVexaminingVtheVprescription,VwhichVofVtheVfollowingVwouldVtheVnurseVexp
ectVtoVfindVdocumented?VSelectVallVthatVapply.
A) NameVofVtheVdrug
B) DosageVofVtheVdrug
C) RouteVofVdrugVadministration
D) TimesVofVdrugVadministration
E) LicensedVprescriber'sVsignatur
eVAns:VA,VB,VC,VD,VE
Feedback:
TheVprescriptionVmustVcontainVtheVclient'sVname,VtheVnameVofVtheVdrug,VtheVdosag
e,VtheVmethodVandVtimesVofVadministration,VandVtheVsignatureVofVtheVlicensedVheal
thVcareVproviderVprescribingVtheVdrug.


9. AfterVteachingVaVgroupVofVnursingVstudentsVaboutVnonprescriptionVdrugs,VtheVnurs
ingVinstructorVdeterminesVthatVtheVteachingVwasVsuccessfulVwhenVtheVstudentsViden
tifyVwhichVofVtheVfollowing?VSelectVallVthatVapply.
A) TheyVrequireVaVlicensedVhealthVcareVprovider'sVsignature.
B) TheyVareVreferredVtoVasVover-the-counterVdrugs.
C) TheyVcanVbeVtakenVwithoutVriskVtoVtheVclient.
D) TheyVhaveVcertainVlabelingVrequirements.
E) TheyVshouldVbeVtakenVonlyVasVdirectedVonVtheVl
abel.VAns:VB,VD,VE
Feedback:
NonprescriptionVdrugsVareVoftenVreferredVtoVasVover-the-
counterV(OTC)Vdrugs.VTheyVdoVnotVrequireVaVprescriptionV(aVlicensedVhealthVcareV
provider'sVsignature)VbutVdoVnotVcomeVwithoutVriskVtoVtheVclient.VTheVfederalVgove
rnmentVhasVimposedVlabelingVrequirementsVofVOTCVdrugsVandVtheyVshouldVonlyVb
eVtakenVasVdirectedVonVtheVlabelVunlessVunderVtheVsupervisionVofVaVhealthVcareVpr
ovider.



PageV
3

, 10. AVnursingVstudentVisVreviewingVinformationVaboutVtheVControlledVSubstancesVA
ctVofV1970.VTheVstudentVwouldVexpectVtoVfindVwhichVofVtheVfollowingVasVbeing
VregulatedVforVdrugsVclassifiedVasVcontrolledVsubstances?VSelectVallVthatVapply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
VAns:VA,VC,VE
Feedback:
TheVControlledVSubstancesVActVofV1970VregulatesVtheVmanufacture,Vdistribution,Va
ndVdispensingVofVdrugsVclassifiedVasVcontrolledVsubstances.VEliminationVrefersVtoVt
heVexcretionVofVdrugsVfromVtheVbody,VaVpharmacokineticVactivity.VTheVactVdoesVno
tVaddressVformulationVofVtheVdrug.


11. WhenVreviewingVinformationVaboutVtheVOrphanVDrugVProgram,VwhichVofVtheVfoll
owingVwouldVtheVnurseVexpectVtoVfind?VSelectVallVthatVapply.
A) TheVprogramVencouragesVtheVdevelopmentVandVmarketingVofVproductsVtoVtre
atVrareVdiseases.
B) TheVprogramVgrantsVprovisionalVapprovalVwithVaVwrittenVcommitmentVfro
mVtheVdrugVcompanyVtoVformallyVdemonstrateVclientVbenefits.
C) TheVprogramVprovidesVforVincentives,VsuchVasVresearchVgrants,VprotocolVassis
tance,VandVspecialVtaxVcredits,VtoVdevelopVproductsVtoVtreatVrareVdiseases.
D) TheVprogramVgrantsV7VyearsVofVexclusiveVmarketingVrightsVtoVtheVmanufact
urerVifVapproved.
E) TheVprogramVacceleratesVapprovalVofVdrugsVbasedVonVpreliminaryVevidenceV
beforeVformalVdemonstrationVofVclientVbenefits.
Ans:V A,VC,VD
Feedback:
TheVOrphanVDrugVProgramVencouragesVtheVdevelopmentVandVmarketingVofVproduct
sVusedVtoVtreatVrareVdiseases.VTheVprogramVprovidesVincentivesVtoVencourageVmanu
facturersVtoVdevelopVorphanVdrugs,VandVifVapproved,VtheVmanufacturerVhasV7Vyears
VofVexclusiveVmarketingVrights.VAcceleratedVprogramsVinvolveVprovisionalVapproval
VandVapprovalVbasedVonVpreliminaryVevidence.




PageV
4